株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

バイオシミラーの世界市場の分析 (2020~30年)

Biosimilars Market Global Report 2020-30

発行 The Business Research Company 商品コード 931981
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.30円で換算しております。
バイオシミラーの世界市場の分析 (2020~30年) Biosimilars Market Global Report 2020-30
出版日: 2020年04月10日 ページ情報: 英文
概要

当レポートでは、世界のバイオシミラーの市場構造・動向について分析し、市場の主な特徴・構造や、全体的な市場規模・成長率の動向見通し (2015~2019年、2023年、2025年、2030年)、製品別・種類別・用途別・地域別・主要国の詳細動向、主なマクロ経済指標との対比、主要企業のプロファイル、近年の主な傾向などを調査しております。

第1章 エグゼクティブサマリー

第2章 バイオシミラー市場の特徴

第3章 バイオシミラー市場:市場規模・成長率

  • 市場規模 (金額ベース、2015~2019年)
  • 市場規模 (金額ベース、2019~2023年、2025年、2030年)
    • 市場促進要因
    • 市場抑制要因

第4章 バイオシミラー市場:分野別の分析

  • 製品別の市場規模 (金額ベース、実績値・予測値)
    • 遺伝子組み換え型非グリコシル化タンパク質
    • 遺伝子組み換え型グリコシル化タンパク質
  • 種類別の市場規模 (金額ベース、実績値・予測値)
    • ヒト成長ホルモン
    • エリスロポエチン
    • モノクローナル抗体
    • インスリン
    • インターフェロン
    • 顆粒球コロニー刺激因子
    • その他
  • 用途別の市場規模 (金額ベース、実績値・予測値)
    • 腫瘍
    • 慢性疾患/自己免疫疾患
    • 成長ホルモン欠乏症
    • 感染症
    • その他

第5章 バイオシミラー市場:地域別・国別分析

  • 地域別の市場規模 (金額ベース、実績値・予測値)
  • 国別の市場規模 (金額ベース、実績値・予測値)

第6章 アジア太平洋地域のバイオシミラー市場

  • 市場概要
  • 製品別の市場規模 (金額ベース、実績値・予測値)
  • 用途別の市場規模 (金額ベース、実績値・予測値)

第7章 中国市場

第8章 インド市場

第9章 日本市場

第10章 オーストラリア市場

第11章 インドネシア市場

第12章 韓国市場

第13章 西欧のバイオシミラー市場

第14章 英国市場

第15章 ドイツ市場

第16章 フランス市場

第17章 東欧のバイオシミラー市場

第18章 ロシア市場

第19章 北米のバイオシミラー市場

第20章 米国市場

第21章 南米のバイオシミラー市場

第22章 ブラジル市場

第23章 中東のバイオシミラー市場

第24章 アフリカのバイオシミラー市場

第25章 バイオシミラー市場:競争環境と企業プロファイル

  • 競争環境
  • 企業プロファイル
    • Pfizer
    • Amgen
    • Biocon
    • Celltrion
    • Dr. Reddy's Laboratories

第26章 バイオシミラー市場における主要な企業合併・買収 (M&A)

第27章 バイオシミラー市場の動向と戦略

第28章 バイオシミラー市場:将来展望と潜在力の分析

第29章 付録

目次

‘Biosimilars Market Global Report 2020-30 ’ from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilars market.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the biosimilars ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? ‘The Biosimilars market global report ’ from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider biosimilars market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The biosimilars market section of the report gives context. It compares the biosimilars market with other segments of the biosimilars market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, biosimilars indicators comparison.

Scope:

  • Markets Covered: 1) By Product: Recombinant Non-glycosylated Proteins; Recombinant Glycosylated Proteins
  • 2) By Types: Human Growth Hormone; Erythropoietin; Monoclonal antibodies; Insulin; Interferon; Granulocyte-Colony Stimulating Factor; Others
  • 3) By Application: Oncology; Chronic and Autoimmune Diseases; Growth Hormone Deficiency; Infectious Diseases; Others
  • Companies Mentioned: Pfizer; Amgen; Biocon; Celltrion; Dr. Reddy's Laboratories
  • Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia
  • Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Biosimilars Market Characteristics

3. Biosimilars Market Size And Growth

  • 3.1. Global Biosimilars Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Biosimilars Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Biosimilars Market Segmentation

  • 4.1. Global Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Recombinant Non-glycosylated Proteins
    • Recombinant Glycosylated Proteins
  • 4.2. Global Biosimilars Market, Segmentation By Types, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Human Growth Hormone
    • Erythropoietin
    • Monoclonal antibodies
    • Insulin
    • Interferon
    • Granulocyte-Colony Stimulating Factor
    • Others
  • 4.3. Global Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Oncology
    • Chronic and Autoimmune Diseases
    • Growth Hormone Deficiency
    • Infectious Diseases
    • Others

5. Biosimilars Market Regional And Country Analysis

  • 5.1. Global Biosimilars Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Biosimilars Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Biosimilars Market

  • 6.1. Asia-Pacific Biosimilars Market Overview
  • 6.2. Asia-Pacific Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Biosimilars Market

  • 7.1. China Biosimilars Market Overview
  • 7.2. China Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Biosimilars Market

  • 8.1. India Biosimilars Market Overview
  • 8.2. India Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Biosimilars Market

  • 9.1. Japan Biosimilars Market Overview
  • 9.2. Japan Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Biosimilars Market

  • 10.1. Australia Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Biosimilars Market

  • 11.1. Indonesia Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Biosimilars Market

  • 12.1. South Korea Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Biosimilars Market

  • 13.1. Western Europe Biosimilars Market Overview
  • 13.2. Western Europe Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Biosimilars Market

  • 14.1. UK Biosimilars Market Overview
  • 14.2. UK Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Biosimilars Market

  • 15.1. Germany Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Biosimilars Market

  • 16.4. France Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Biosimilars Market

  • 17.1. Eastern Europe Biosimilars Market Overview
  • 17.2. Eastern Europe Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Biosimilars Market

  • 18.1. Russia Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Biosimilars Market

  • 19.1. North America Biosimilars Market Overview
  • 19.2. North America Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Biosimilars Market

  • 20.1. USA Biosimilars Market Overview
  • 20.2. USA Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Biosimilars Market

  • 21.1. South America Biosimilars Market Overview
  • 21.2. South America Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Biosimilars Market

  • 22.1. Brazil Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Biosimilars Market

  • 23.1. Middle East Biosimilars Market Overview
  • 23.2. Middle East Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Biosimilars Market

  • 24.1. Africa Biosimilars Market Overview
  • 24.2. Africa Biosimilars Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Biosimilars Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Biosimilars Market Competitive Landscape And Company Profiles

  • 25.1. Biosimilars Market Competitive Landscape
  • 25.2. Biosimilars Market Company Profiles
    • 25.2.1. Pfizer
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Amgen
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Biocon
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Celltrion
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Dr. Reddy's Laboratories
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Biosimilars Market

27. Biosimilars Market Trends And Strategies

28. Biosimilars Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer